Heiddis B Valdimarsdottir | Mount Sinai

Biography

Research Topics

Behavioral Health, Breast Cancer, Cancer, Cancer Genetics, Chronic Fatigue Syndrome, Depression, Hematopoiesis, Immunology, Prostate, Psychiatry

Research

Psychological, Behavioral, And Biological Consequences Of Being At Familial Risk For Cancer

Heiddis Valdimarsdottir, Ph.D.'s current research investigates the psychological, behavioral, and biological consequences of being at familial risk for cancer, including investigating the psychosocial issues surrounding genetic testing for cancer susceptibility. Current research includes studies on testing interventions for reducing distress and increasing participants' understanding of the implications of testing among African American women, as well as investigating psychosocial factors involved in seeking genetic testing and the consequences of testing among Ashkenazi Jewish women.

Education

Bachelors of Arts (BA), University of Iceland

Doctorate of Psychology (PhD), S.U.N.Y. at Stony Brook

Postdoctoral Research Associate, S.U.N.Y. at Stony Brook

Postdoctoral Fellowship, Memorial Sloan Kettering Cancer Center

Publications

153

Publications

Selected Publications

Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes. Savannah Binion, Lia J. Sorgen, Beth N. Peshkin, Heiddis Valdimarsdottir, Claudine Isaacs, Rachel Nusbaum, Kristi D. Graves, Tiffani DeMarco, Marie Wood, Wendy McKinnon, Judy Garber, Shelley McCormick, Mary K. Ladd, Marc D. Schwartz. Journal of Telemedicine and Telecare

A Virtual Reality Courtroom for Survivors of Sexual Violence: A Mixed-Method Pilot Study on Application Possibilities. Rannveig Sigurvinsdottir, Hildur Skúladóttir, Hildur Fjóla Antonsdóttir, Paola Cardenas, Margrét Tórshamar Georgsdóttir, Malena Írisardóttir Þórisdóttir, Erla Katrín Jónsdóttir, Magdalena Konop, Heiðdís B. Valdimarsdóttir, Hannes Högni Vilhjálmsson, Bryndís Björk Ásgeirsdóttir. Violence Against Women

Biological and psychological predictors of cognitive function in breast cancer patients before surgery. Snaefridur Gudmundsdottir Aspelund, Thorhildur Halldorsdottir, Gudjon Agustsson, Hannah Ros Sigurdardottir Tobin, Lisa M. Wu, Ali Amidi, Kamilla R. Johannsdottir, Susan K. Lutgendorf, Rachel Telles, Huldis Franksdottir Daly, Kristin Sigurdardottir, Heiddis B. Valdimarsdottir, Birna Baldursdottir. Supportive Care in Cancer

View All Publications

Office Locations

Icahn (East) Building Floor 2nd Floow Room 2-70

1425 Madison Ave

New York, NY 10029

212-659-5559

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Valdimarsdottir did not report having any of the following types of financial relationships with industry and other outside entities during 2023 and/or 2024: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Valdimarsdottir did not report having any of the following types of financial relationships with industry and other outside entities during 2023 and/or 2024: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.